Market Value9,361,492,374
Total Holdings95
File Date2025-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
GLUE / Monte Rosa Therapeutics, Inc.
IMTX / Immatics N.V.
RLAY / Relay Therapeutics, Inc.
HOOK / HOOKIPA Pharma Inc.
PCVX / Vaxcyte, Inc.
SANA / Sana Biotechnology, Inc.
CELC / Celcuity Inc.
INCY / Incyte Corporation
KNSA / Kiniksa Pharmaceuticals, Ltd.
MDGL / Madrigal Pharmaceuticals, Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
IRON / Disc Medicine, Inc.
LPTX / Leap Therapeutics, Inc.
SMMT * / Summit Therapeutics Inc.
REPL / Replimune Group, Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
BCAX / Bicara Therapeutics Inc.
IONS / Ionis Pharmaceuticals, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
ABCL / AbCellera Biologics Inc.
ONC / BeOne Medicines AG - Depositary Receipt (Common Stock)
TRDA / Entrada Therapeutics, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
VERV / Verve Therapeutics, Inc.
CLDX / Celldex Therapeutics, Inc.
XENE / Xenon Pharmaceuticals Inc.
BNTX / BioNTech SE - Depositary Receipt (Common Stock)
INSM / Insmed Incorporated
NGNE / Neurogene Inc.
IGMS / IGM Biosciences, Inc.
RVMD / Revolution Medicines, Inc.
IDYA / IDEAYA Biosciences, Inc.
CERS / Cerus Corporation
KALA / KALA BIO, Inc.
SGMT / Sagimet Biosciences Inc.
AVTE / Aerovate Therapeutics, Inc.
KOD / Kodiak Sciences Inc.
ROIV / Roivant Sciences Ltd.
NTLA / Intellia Therapeutics, Inc.
AKRO / Akero Therapeutics, Inc.
FATE / Fate Therapeutics, Inc.
VIR / Vir Biotechnology, Inc.
ACRV / Acrivon Therapeutics, Inc.
TYRA / Tyra Biosciences, Inc.
SRZNW / Surrozen, Inc. - Equity Warrant
IPSC / Century Therapeutics, Inc.
KRYS / Krystal Biotech, Inc.
CRSP / CRISPR Therapeutics AG
EWTX / Edgewise Therapeutics, Inc.
KYMR / Kymera Therapeutics, Inc.
PRAX / Praxis Precision Medicines, Inc.
MRSN / Mersana Therapeutics, Inc.
Ionis Pharmaceuticals, Inc. / Note 1.75% 6/15/2028 (462222AF7)
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
PRLD / Prelude Therapeutics Incorporated
CTNM / Contineum Therapeutics, Inc.
NMRA / Neumora Therapeutics, Inc.
CADL / Candel Therapeutics, Inc.
NAMS / NewAmsterdam Pharma Company N.V.
WVE / Wave Life Sciences Ltd.
ELVN / Enliven Therapeutics, Inc.
ALGS / Aligos Therapeutics, Inc.
ALMS / Alumis Inc.
CMPX / Compass Therapeutics, Inc.
TARA / Protara Therapeutics, Inc.
VTVT / vTv Therapeutics Inc.
ARVN / Arvinas, Inc.
US457669AB50 / INSMED INC CONV 0.75% 06/01/2028
CRNX / Crinetics Pharmaceuticals, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
RYTM / Rhythm Pharmaceuticals, Inc.
ALKS / Alkermes plc
IMVT / Immunovant, Inc.
PMVP / PMV Pharmaceuticals, Inc.
ALEC / Alector, Inc.
PTCT / PTC Therapeutics, Inc.
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
NRIX / Nurix Therapeutics, Inc.
XNCR / Xencor, Inc.
GRAL / GRAIL, Inc.
MIRM / Mirum Pharmaceuticals, Inc.
TNGX / Tango Therapeutics, Inc.
PRME / Prime Medicine, Inc.
TCRX / TScan Therapeutics, Inc.
MRUS / Merus N.V.
PFE / Pfizer Inc.
SKYE / Skye Bioscience, Inc.
DNLI / Denali Therapeutics Inc.
BMEA / Biomea Fusion, Inc.
TSHA / Taysha Gene Therapies, Inc.
ARCT / Arcturus Therapeutics Holdings Inc.
OPT / Opthea Limited - Depositary Receipt (Common Stock)
GBIO / Generation Bio Co.
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
FHTX / Foghorn Therapeutics Inc.
STOK / Stoke Therapeutics, Inc.
SERA / Sera Prognostics, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
DSGN / Design Therapeutics, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
RCKT / Rocket Pharmaceuticals, Inc.
DYN / Dyne Therapeutics, Inc.
TSVT / 2seventy bio, Inc.